Presenter: Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
0:00
In episode 480, James and Mike talk about two recent meta-analyses that have done a solid job of looking at the impact of lowering blood pressure and using SGLT-2s and GLP-1s to reduce risk. Both publications lend credence to the concept of focusing much more on risk reduction goals than blood pressure or glucose thresholds….
Latest Podcasts
BS Medicine Episode #624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?
In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the…
FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale
Le groupe d'intérêt des membres sur la santé des patients 2SLGBTQ+ a collaboré avec projet NUANCES, centre de soins en diversité sexuelle et de genre. Dre Judith Lajeunesse et Charlotte…
FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care
This podcast discusses two of the most common gender-affirming surgeries - vaginoplasty in a transfeminine patient and top surgery or mastectomy in a trans masculine patient. These are emotionally high…
November 12, 2021
Presenter(s):
Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
Please provide any additional comments (optional).